Trial of Merck's Covid drug in Vietnam records zero deaths: health ministry

A box of molnupiravir, a Covid-19 drug developed by U.S. pharmaceutical firm Merck that is being tested in Vietnam. Photo by VnExpress

By Le Nga

A trial for Covid-19 drug molnupiravir developed by U.S. pharmaceutical firm Merck in Vietnam saw no fatalities, the Ministry of Health announced Saturday.

The trial was conducted in 22 cities and provinces and showed the drug is safe and effective in reducing viral load, infectivity and treatment time.

Following five days of usage, the percentage of coronavirus patients with low viral loads increased from 72.1 to 99.1 percent. After 14 days, the percentage was nearly 100 percent. Only around 0.02-0.06 percent of patients grew severe, and there were no deaths, according to the health ministry.

Full story: https://e.vnexpress.net/news/news/trial-of-merck-s-covid-drug-in-vietnam-records-zero-deaths-health-ministry-4382299.html

-- © Copyright VN EXPRESS 2021-11-08